Matches in SemOpenAlex for { <https://semopenalex.org/work/W1537942001> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W1537942001 endingPage "516" @default.
- W1537942001 startingPage "516" @default.
- W1537942001 abstract "Immunoglobulin A (IgA) nephropathy (IgAN) represents a common glomerular disease treated by various therapeutic regimens. We studied 50 IgAN patients to determine the effect of different regimens selected according to severity of the disease on the clinical outcome of patients over a follow-up period of five years. Patients with normal renal function and proteinuria <1 g/24-h received no treatment (Group A, n = 6). Thοse with normal renal function, proteinuria >1 g/24-h and mild to moderate histological lesions received angiotensin-converting enzyme inhibitors (ACEi) and corticosteroids (Group B, n = 23). Patients with baseline serum creatinine (Scr) <2.5 mg/dL, proteinuria >3.5 g/24-h and severe histological lesions received ACEi, corticosteroids and other immunosuppressive drugs (Group C, n = 18). Finally, patients with Scr >2.5 mg/dL, glomerulosclerosis and tubulointerstitial fibrosis received ACEi and fish oil (Group D, n = 3). Doubling of baseline Scr was observed in nine (18%) patients; two (8.7%) patients from Group B, five (27.7%) patients from Group C and two (66.7%) patients from Group D. Of the seven (14%) patients who reached end-stage renal disease, one (4.3%) patient was from Group B, four (21.0%) patients were from Group C and two (66.7%) patients were from Group D. Reduction of proteinuria was observed in all (100%) patients from Group B and in 15 (83.3%) patients from Group C. Adverse reactions occurred in three of 18 (16%) patients treated with immunosuppressive drugs. The choice of therapeutic regimen used in the treatment of patients with IgAN could be based on the severity of clinical and histological involvement in order to achieve the maximum effect with the least of adverse reactions." @default.
- W1537942001 created "2016-06-24" @default.
- W1537942001 creator A5010042274 @default.
- W1537942001 creator A5013988359 @default.
- W1537942001 creator A5036521084 @default.
- W1537942001 creator A5058692273 @default.
- W1537942001 creator A5076482647 @default.
- W1537942001 creator A5086154946 @default.
- W1537942001 date "2015-01-01" @default.
- W1537942001 modified "2023-09-26" @default.
- W1537942001 title "Treatment of IgA nephropathy based on the severity of clinical and histological features" @default.
- W1537942001 doi "https://doi.org/10.4103/1319-2442.157356" @default.
- W1537942001 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26022022" @default.
- W1537942001 hasPublicationYear "2015" @default.
- W1537942001 type Work @default.
- W1537942001 sameAs 1537942001 @default.
- W1537942001 citedByCount "2" @default.
- W1537942001 countsByYear W15379420012017 @default.
- W1537942001 countsByYear W15379420012022 @default.
- W1537942001 crossrefType "journal-article" @default.
- W1537942001 hasAuthorship W1537942001A5010042274 @default.
- W1537942001 hasAuthorship W1537942001A5013988359 @default.
- W1537942001 hasAuthorship W1537942001A5036521084 @default.
- W1537942001 hasAuthorship W1537942001A5058692273 @default.
- W1537942001 hasAuthorship W1537942001A5076482647 @default.
- W1537942001 hasAuthorship W1537942001A5086154946 @default.
- W1537942001 hasBestOaLocation W15379420011 @default.
- W1537942001 hasConcept C126322002 @default.
- W1537942001 hasConcept C134018914 @default.
- W1537942001 hasConcept C159641895 @default.
- W1537942001 hasConcept C2777785397 @default.
- W1537942001 hasConcept C2778415529 @default.
- W1537942001 hasConcept C2778653478 @default.
- W1537942001 hasConcept C2779561371 @default.
- W1537942001 hasConcept C2780091579 @default.
- W1537942001 hasConcept C2780306776 @default.
- W1537942001 hasConcept C2781184683 @default.
- W1537942001 hasConcept C2781413609 @default.
- W1537942001 hasConcept C555293320 @default.
- W1537942001 hasConcept C71924100 @default.
- W1537942001 hasConcept C90924648 @default.
- W1537942001 hasConceptScore W1537942001C126322002 @default.
- W1537942001 hasConceptScore W1537942001C134018914 @default.
- W1537942001 hasConceptScore W1537942001C159641895 @default.
- W1537942001 hasConceptScore W1537942001C2777785397 @default.
- W1537942001 hasConceptScore W1537942001C2778415529 @default.
- W1537942001 hasConceptScore W1537942001C2778653478 @default.
- W1537942001 hasConceptScore W1537942001C2779561371 @default.
- W1537942001 hasConceptScore W1537942001C2780091579 @default.
- W1537942001 hasConceptScore W1537942001C2780306776 @default.
- W1537942001 hasConceptScore W1537942001C2781184683 @default.
- W1537942001 hasConceptScore W1537942001C2781413609 @default.
- W1537942001 hasConceptScore W1537942001C555293320 @default.
- W1537942001 hasConceptScore W1537942001C71924100 @default.
- W1537942001 hasConceptScore W1537942001C90924648 @default.
- W1537942001 hasIssue "3" @default.
- W1537942001 hasLocation W15379420011 @default.
- W1537942001 hasLocation W15379420012 @default.
- W1537942001 hasOpenAccess W1537942001 @default.
- W1537942001 hasPrimaryLocation W15379420011 @default.
- W1537942001 hasRelatedWork W1967314540 @default.
- W1537942001 hasRelatedWork W2042710484 @default.
- W1537942001 hasRelatedWork W2058466993 @default.
- W1537942001 hasRelatedWork W2101525493 @default.
- W1537942001 hasRelatedWork W2113389249 @default.
- W1537942001 hasRelatedWork W2184243264 @default.
- W1537942001 hasRelatedWork W2560482142 @default.
- W1537942001 hasRelatedWork W2607916424 @default.
- W1537942001 hasRelatedWork W3148712325 @default.
- W1537942001 hasRelatedWork W4214885596 @default.
- W1537942001 hasVolume "26" @default.
- W1537942001 isParatext "false" @default.
- W1537942001 isRetracted "false" @default.
- W1537942001 magId "1537942001" @default.
- W1537942001 workType "article" @default.